Gene · 6272
Papers2,809
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
61 to 80 of 2,809
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Serum sortilin as a potential diagnostic and therapeutic target for cardiovascular calcification in uremic patients: A single-center prospective and observational study. | Clin Chim Acta | 2026 | 40858200 | PubTator, text mining | PubMed |
| Inhibition of sortilin reduces neuronal and vascular damage after ischemia/reperfusion through reduced inflammatory and autophagy actions in retinal Müller cells. | Mol Vis | 2025 | 41867371 | PubTator, text mining | PubMed |
| Computational Identification of Potent Multitarget Natural Ligands for Alzheimer's Disease Therapeutics. | Scientifica (Cairo) | 2025 | 41523616 | PubTator, text mining | PubMed |
| Machine Learning-Driven Precision Nutrition: A Paradigm Evolution in Dietary Assessment and Intervention. | Nutrients | 2025 | 41515163 | PubTator, text mining | PubMed |
| Pathogenesis-Guided Biomarker Assessment: A Shift in Prostate Cancer Diagnostics. | Int J Mol Sci | 2025 | 41465218 | PubTator, text mining | PubMed |
| Association of Serum Sortilin and Insulin Resistance in Patients with Gestational Diabetes Mellitus. | EJIFCC | 2025 | 41459178 | PubTator, text mining | PubMed |
| Endocrine complications in patients with β-thalassemia major receiving iron-chelation therapy. | Ther Adv Endocrinol Metab | 2025 | 41425691 | PubTator, text mining | PubMed |
| Decoding the distinct immune landscape and possible regulatory mechanisms of autoimmune hepatitis through integrated single-cell and bulk RNA sequencing. | PLoS One | 2025 | 41343465 | PubTator, text mining | PubMed |
| Integrated single-cell RNA-seq and bulk RNA-seq analysis to investigate key adipogenesis genes in adipose-derived stem cells. | PLoS One | 2025 | 41325391 | PubTator, text mining | PubMed |
| Targeting Prostate Cancer Cells Using Anti-Sortilin and Anti-Syndecan-1 Antibody Drug Conjugates. | Int J Mol Sci | 2025 | 41303628 | PubTator, text mining | PubMed |
| Brain-Derived Neurotrophic Factor Trafficking via the Regulated Secretory Pathway: Mechanisms and Disease Implications. | Mol Neurobiol | 2025 | 41254423 | PubTator, text mining | PubMed |
| Proteome-Wide Monitoring of Drug Action in Living Cells Using a Novel Label-Free Solvent-Based Shift Assay. | Mol Cell Proteomics | 2025 | 41202878 | PubTator, text mining | PubMed |
| A Modification to Two-Stage Least Squares With Genetic Applications. | Stat Med | 2025 | 41201239 | PubTator, text mining | PubMed |
| Novel protein targets for type 2 diabetes prevention and their mediating role in the diet-disease relationship: evidence from 2 population-based cohorts and a Mendelian randomization analysis. | Am J Clin Nutr | 2025 | 41193035 | PubTator, text mining | PubMed |
| Targeting Granulin Haploinsufficiency in Frontotemporal Dementia: From Genetic Mechanisms to Therapeutics. | Int J Mol Sci | 2025 | 41155255 | PubTator, text mining | PubMed |
| A Neural-Glial Model of the ApoE-SORT1-FABP7 Axis Tied to Sleep Disruption and Alzheimer's Disease Pathophysiology. | Biomolecules | 2025 | 41154661 | PubTator, text mining | PubMed |
| Interaction of sortilin with apolipoprotein E3 enables neurons to use long-chain fatty acids as alternative metabolic fuel. | Nat Metab | 2025 | 41102453 | PubTator, text mining | PubMed |
| ACE-mediated Glycosylation Stabilizes PSAP To Promote GPR37-dependent Macrophage-Nucleus Pulposus Cells Crosstalk and TGFβ Signaling in Alleviating Intervertebral Disc Degeneration. | Adv Sci (Weinh) | 2025 | 41085015 | PubTator, text mining | PubMed |
| Vesicle adaptors in malaria parasites show conservation and flexibility of protein sorting machinery. | J Cell Biol | 2025 | 41082687 | PubTator, text mining | PubMed |
| Comparative effects of empagliflozin and vildagliptin on inflammation and atrial function in patients with type 2 diabetes and coronary artery disease: EMPA-VILDA-Response trial. | Eur J Pharmacol | 2025 | 41077239 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6272/papers?page=4